Cancer Treat Rep. 1978 Mar;62(3):405-8.

Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.

Yap HY, Salem P, Hortobagyi GN, Bodey GP Sr, Buzdar AU, Tashima CK, Blumenschein GR.

Abstract

Twenty-six patients with metastatic breast cancer received cis-dichlorodiammineplatinum(II) either as a single dose of 100 mg/m2 iv every 3--4 weeks or as a continuous 5-day infusion of 20 mg/m2/day at 4-week intervals. Fourteen patients were treated with the single-dose schedule and 12 patients were treated with the continuous 5-day infusion. No significant response was observed with either dose schedule. Aside from a reduction in the frequency and severity of gastrointestinal toxicity with the continuous 5-day infusion, no real difference was seen with regard to renal and hematologic toxicity with either dose schedule.

PMID:: 348308; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Cisplatin

LinkOut - more resources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Review Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin. [J Infus Chemother. 1996]
Review Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U, Wilke H, Seeber S. J Infus Chemother. 1996 Summer; 6(3):127-32.
Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion. [Cancer Treat Rep. 1978]
Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion.
Salem P, Hall SW, Benjamin RS, Murphy WK, Wharton JT, Bodey GP. Cancer Treat Rep. 1978 Oct; 62(10):1553-5.
A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer. Two dose schedules. [J Cancer Res Clin Oncol. 1984]
A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer. Two dose schedules.
Martino S, Samal BA, Singhakowinta A, Yoshida S, Mackenzie M, Jain J, Vaitkevicius VK. J Cancer Res Clin Oncol. 1984; 108(3):354-6.
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. [Cancer Chemother Pharmacol. 1995]
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Vokes EE, Haraf DJ, Drinkard LC, Hoffman PC, Ferguson MK, Vogelzang NJ, Watson S, Lane NJ, Golomb HM. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
Review Gemcitabine and docetaxel in metastatic breast cancer. [Oncology (Williston Park). 2004]
Review Gemcitabine and docetaxel in metastatic breast cancer.
Seidman AD. Oncology (Williston Park). 2004 Dec; 18(14 Suppl 12):13-6.

See reviews... See all...

Cited by 4 PubMed Central articles

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients. [Ann Oncol. 2011]
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
Vollebergh MA, Lips EH, Nederlof PM, Wessels LF, Schmidt MK, van Beers EH, Cornelissen S, Holtkamp M, Froklage FE, de Vries EG, et al. Ann Oncol. 2011 Jul; 22(7):1561-70. Epub 2010 Dec 6.
Review Triple-negative breast cancer: role of specific chemotherapy agents. [Cancer J. 2010]
Review Triple-negative breast cancer: role of specific chemotherapy agents.
Isakoff SJ. Cancer J. 2010 Jan-Feb; 16(1):53-61.
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. [Breast Cancer Res. 2007]
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells.
Yaar M, Eller MS, Panova I, Kubera J, Wee LH, Cowan KH, Gilchrest BA. Breast Cancer Res. 2007; 9(1):R13.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
Cancer Treat Rep. 1978 Mar ;62(3):405-8.

PubMed
Benign and malignant breast disease: initial study results of serum and breast f...
Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens.
J Natl Cancer Inst. 1987 Nov ;79(5):949-60.

PubMed
Ascertainment in the sequential sampling of pedigrees.
Ascertainment in the sequential sampling of pedigrees.
Clin Genet. 1977 Oct ;12(4):208-12.

PubMed
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens...
DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Cancer. 1988 Feb 1 ;61(3):420-7.

PubMed
The determination of twin zygosity by means of a mailed questionnaire.
The determination of twin zygosity by means of a mailed questionnaire.
Acta Genet Med Gemellol (Roma). 1979 ;28(3):225-36.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information